Essex Financial Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Buy
5,122
+121
+2% +$23.3K 0.06% 289
2025
Q4
$919K Sell
5,001
-356
-7% -$62.4K 0.05% 304
2025
Q3
$822K Buy
5,357
+6
+0.1% +$908 0.05% 316
2025
Q2
$748K Sell
5,351
-82
-2% -$11.5K 0.05% 325
2025
Q1
$799K Sell
5,433
-28
-0.5% -$4.05K 0.06% 283
2024
Q4
$716K Buy
5,461
+47
+0.9% +$6.58K 0.05% 305
2024
Q3
$837K Sell
5,414
-10
-0.2% -$1.61K 0.06% 279
2024
Q2
$888K Buy
5,424
+2,055
+61% +$309K 0.07% 262
2024
Q1
$456K Buy
3,369
+202
+6% +$26.7K 0.04% 341
2023
Q4
$427K Buy
3,167
+164
+5% +$21.3K 0.04% 329
2023
Q3
$407K Sell
3,003
-162
-5% -$22.1K 0.05% 319
2023
Q2
$453K Buy
3,165
+220
+7% +$32.4K 0.05% 301
2023
Q1
$409K Buy
2,945
+745
+34% +$100K 0.04% 324
2022
Q4
$298K Hold
2,200
0.03% 364
2022
Q3
$241K Buy
2,200
+84
+4% +$10.7K 0.03% 388
2022
Q2
$280K Hold
2,116
0.03% 369
2022
Q1
$281K Buy
2,116
+7
+0.3% +$839 0.03% 397
2021
Q4
$246K Hold
2,109
0.02% 413
2021
Q3
$253K Buy
+2,109
New +$246K 0.03% 385

Other funds holding AZN

Essex Financial Services's AZN Position: Q1 2026 in Review

Essex Financial Services increased its AstraZeneca (AZN) stake by 2.4% in Q1 2026, buying an estimated $23.3K and bringing the position to 5,122 shares worth $1M. The position accounts for 0.06% of the portfolio, ranked #289.

Essex Financial Services first reported a position in AZN in Q3 2021 and has held it in 19 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Essex Financial Services held 5,122 shares of AstraZeneca worth $1M as of Q1 2026.
  • Essex Financial Services bought 121 AstraZeneca shares in Q1 2026, an estimated $23.3K.
  • AstraZeneca made up 0.06% of Essex Financial Services's portfolio in Q1 2026, its #289 holding.
  • Essex Financial Services first reported a position in AstraZeneca in Q3 2021 and has held it in 19 quarters since.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.